Search
Selected: U

Use of colostrinin, constituent peptides thereof, and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of colostrinin, constituent peptides thereof, and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of colostrinin, constituent peptides thereof, and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of colostrinin, constituent peptides thereof, and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of colostrinin, constituent peptides thereof, and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of compositions of matter containing N-acylates of alpha ami

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of compounds having the biological activity of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of compounds that reduce alpha2-antiplasmin in vivo for...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of conantokins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of conantokins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of conantokins for treating pain

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of copolymer 1 and related peptides and polypeptides and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of copolymer 1 and related peptides and polypeptides and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of CRF-antagonists for treating emesis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of cross-linked hemoglobin in treating subarachnoid hemorrha

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of cyclic depsipeptides having 12 ring atoms for combating e

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of cytokine inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of cytokine inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of cytokine restraining agents to treat inflammatory bowel d

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Use of D-glucopyranuronic acids and their derivatives for incorp

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent

  [ 0.00 ] – not rated yet Voters 0   Comments 0
  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.